Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Slevin

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
British Journal of Urology|November 1, 1995
Ethical issues in cancer treatmentR T Penson, L Doyal, M L Slevin
British Journal of Hospital Medicine|November 1, 1991
Carcinoid tumours and interferon therapy: an undervalued treatmentC A Barrett, C H Smith, M L Slevin
Cancer Chemotherapy and Pharmacology|January 1, 1983
Re: The relationship between serum alkaline phosphatase and vincristine neuropathyM L Slevin, V J Harvey, P F Wrigley
Cytokine|November 1, 1990
Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humansM Lantz, S Malik, M L Slevin, et al.
Journal of Chromatography|September 9, 1988
An improved method for the simultaneous determination of morphine and its principal glucuronide metabolitesS P Joel, R J Osborne, M L Slevin
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
5-Fluorouracil-induced Raynaud's phenomenonD Papamichael, N Amft, M L Slevin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Stability of the i.v. and oral formulations of etoposide in solutionS P Joel, P I Clark, M L Slevin
Cancer Chemotherapy and Pharmacology|January 1, 1983
Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancerM L Slevin, V J Harvey, P F Wrigley
British Medical Journal (Clinical Research Ed.)|June 14, 1986
Morphine intoxication in renal failure: the role of morphine-6-glucuronideR J Osborne, S P Joel, M L Slevin
British Journal of Cancer|March 1, 1991
The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapyP W Johnson, R King, M L Slevin, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Urology|November 1, 1995
Ethical issues in cancer treatmentR T Penson, L Doyal, M L Slevin
British Journal of Hospital Medicine|November 1, 1991
Carcinoid tumours and interferon therapy: an undervalued treatmentC A Barrett, C H Smith, M L Slevin
Cancer Chemotherapy and Pharmacology|January 1, 1983
Re: The relationship between serum alkaline phosphatase and vincristine neuropathyM L Slevin, V J Harvey, P F Wrigley
Cytokine|November 1, 1990
Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humansM Lantz, S Malik, M L Slevin, et al.
Journal of Chromatography|September 9, 1988
An improved method for the simultaneous determination of morphine and its principal glucuronide metabolitesS P Joel, R J Osborne, M L Slevin
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
5-Fluorouracil-induced Raynaud's phenomenonD Papamichael, N Amft, M L Slevin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Stability of the i.v. and oral formulations of etoposide in solutionS P Joel, P I Clark, M L Slevin
Cancer Chemotherapy and Pharmacology|January 1, 1983
Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancerM L Slevin, V J Harvey, P F Wrigley
British Medical Journal (Clinical Research Ed.)|June 14, 1986
Morphine intoxication in renal failure: the role of morphine-6-glucuronideR J Osborne, S P Joel, M L Slevin
British Journal of Cancer|March 1, 1991
The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapyP W Johnson, R King, M L Slevin, et al.
Pageof 14